MIRA INFORM REPORT

 

 

Report No. :

495272

Report Date :

28.02.2018

 

 

 

 

Email :

nishit.jobalia@inventiahealthcare.com

 

 

IDENTIFICATION DETAILS

 

Name :

INVENTIA HEALTHCARE PRIVATE LIMITED (w.e.f. 16.03.2009)

 

 

Formerly Known As :

THEMIS LABORATORIES PRIVATE LIMITED (w.e.f. 18.03.2002)

 

ANKUR PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

Unit 703 and 704, 7th Floor, Hubtown Solaris, N S Phadke Marg, Andheri (East), Mumbai – 400069, Maharashtra

Tel. No.:

91- 22-67163000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

27.09.1985

 

 

Com. Reg. No.:

11-037597

 

 

Capital Investment / Paid-up Capital :

INR 78.330 Million

 

 

CIN No.:

[Company Identification No.]

U24239MH1985PTC037597

 

 

IEC No.:

[Import-Export Code No.]

Not Available

 

 

TIN No.:

27220000409

 

 

PAN No.:

[Permanent Account No.]

AABCT5371R

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

GSTN :

[Goods & Service Tax Registration No.]

27AABCT5371R1ZN

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in the manufacturing of pharmaceuticals formulations with focus developing value-added (Novel Drug Delivery Systems) single ingredients and novel combination products in the solid oral dosage forms. (Registered Activity)

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 4819000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 1985 and it is engaged in business of manufacturing pharmaceutical formulation. It is an old and established company having fine track record.

 

For the financial year 2017, the company has achieved decent growth in its revenue as compared to its previous year along with good profit margin during the year.

 

Rating reflects company’s sound financial profile marked by favourable profitability, good net worth base along with strong debt protection metrics.

 

Rating continue to derive strength from its long and established track record of its business operation backed by established market position and extensive experience of the promoters in the pharmaceutical industry.

 

However, these rating strengths gets partially offset by intense competition in the international market, and growing regulatory scrutiny in emerging market, along with growing competition, substantial investment in infrastructure and R&D which impact in  profitability pressure amongst the major players.

 

Payments seems to be regular.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 28.02.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED BY

 

Name :

Mr. Sanjay

Designation :

Not Divulged

Contact No.:

91-22-67163000

 

Management non-cooperative (Tel No.: 91-22-67163600)

 

LOCATIONS

 

Registered Office/ Corporate Office :

Unit 703 and 704, 7th Floor, Hubtown Solaris, N S Phadke Marg, Andheri (East), Mumbai – 400069, Maharashtra, India

Tel. No.:

91- 22-67163000

Fax No.:

91- 22-67163100

E-Mail :

rupa.desai@inventiahealthcare.com

Website :

www.inventiahealthcare.com

 

 

Thane Office :

A-215, Road No. 30, Wagle Industrial Estate, Thane (West) – 400 604, Maharashtra, India

Tel. No.:

91-22-67163600

 

 

Manufacturing Site:

F1-F1/1, Additional Ambernath, M.I.D.C., Ambernath (East), District Thane - 421506, Maharashtra, India

Tel. No.:

91-251-6614000

Fax No.:

91-251-6614100

 

 

R&D Center:

A-214, Road No. 30, Wagle Industrial Estate, Thane – 400604, Maharashtra, India

Tel. No.:

91-22-67163400

Fax No.:

91-22-67163500

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Janak Ramanlal Shah

Designation :

Managing Director

Address :

30, Saujanya, Vallabh Nagar Society, N. S. Road No.3, JVPD Scheme, Vile Parle (West), Mumbai-400056, Maharashtra, India 

Date of Birth/Age :

19.11.1947

Date of Appointment :

01.11.1991

PAN No.:

AACPJ4006B

DIN No.:

00019819

 

 

Name :

Mrs. Maya Janak Shah

Designation :

Whole-Time Director

Address :

30, Saujanya, Vallabh Nagar Society, N. S. Road No.3, JVPD Scheme, Vile Parle (West), Mumbai-400056, Maharashtra, India 

Date of Birth/Age :

08.04.1950

Date of Appointment :

27.09.1985

PAN No.:

AANPS8887N

DIN No.:

00019904

 

 

Name :

Mr. Ankur Janak Shah

Designation :

Director

Address :

30, Saujanya, Vallabh Nagar Society, N. S. Road No.3, JVPD Scheme, Vile Parle (West), Mumbai-400056, Maharashtra, India 

Date of Birth/Age :

27.10.1977

Date of Appointment :

04.07.2008

PAN No.:

AALPS9153R

DIN No.:

01656781

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U73100MH2012PTC234798

INVENGENE BIOSCIENCES PRIVATE LIMITED

22/08/2012

-

 

 

Name :

Dr. Prabuddha Prabodhranjan Ganguli

Designation :

Director

Address :

201 Sunview Heights 262 Sher- E- Punjab, Andheri (East), Mumbai-400093, Maharashtra, India 

Date of Birth/Age :

23.06.1948

Date of Appointment :

04.06.2010

DIN No.:

03091961

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U74999MH1999NPL120729

INTELLECTUAL PROPERTY LAW PRACTITIONERS ASSOCIATION

28/09/2015

-

 

 

Name :

Mr. Sri Krishna Akkipeddi

Designation :

Director

Address :

1347-C-1, First Floor, Vasant Kunj, New Delhi-110070, India

Date of Birth/Age :

18.03.1956

Date of Appointment :

04.07.2008

DIN No.:

07498771

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U85110OR2015PTC019174

CURE2HEALTH PRIVATE LIMITED

25/02/2017

-

LLPIN/FLLPIN

LLP Name

Begin Date

End Date

AAH-3388

SKA PROFESSIONAL ADVISORY LLP

07/09/2016

-

 

 

Name :

Mr. Bharat Bakhshi

Designation :

Nominee Director

Address :

Villa No. 284, Block-Y, Tatvam Villas, Sector-48, Sohna Road, Gurugram-122018, Haryana, India 

Date of Birth/Age :

05.09.1968

Date of Appointment :

04.07.2008

DIN No.:

01381524

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U67190MH1999PLC119009

CENTRUMDIRECT LIMITED

29/03/2017

-

U92190MH2007PLC175250

THRILL PARK LIMITED

30/09/2015

-

 

 

KEY EXECUTIVES

 

Name :

Ms. Rupa D Desai

Designation :

Company Secretary

Address :

Flat No 1, Archana CHS Tagore Road, Santacruz (West), Mumbai-400054, Maharashtra, India 

Date of Birth/Age :

02.04.1972

Date of Appointment :

19.07.2010

PAN No.:

ADKPR1935N

 

MAJOR SHAREHOLDERS

 

As on 02.06.2017

 

Names of Shareholders

 

No. of Shares

Janak Ramanlal Shah

 

3254350

Maya Janak Shah

 

2720650

Ankur Janak Shah

 

12500

Vishal Janak Shah

 

12000

Gaurang Hasmukhlal Thanawala

 

100

Daksha Gaurang Thanawala

 

100

Sachi Gaurang Thanawala

 

100

Dwiti Gaurang Thanawala

 

100

Varun Gaurang Thanawala

 

100

NYLIM Jacob Ballas India Fund III LLC and its Affiliates

 

1833000

Total

 

7833000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 02.06.2017

 

Category

Percentage

Promoters (Individual/Hindu Undivided Family – Indian)

76.28

Public/Other than promoters (Individual/Hindu Undivided Family – Indian)

0.01

Public/Other than promoters (Others - Promoter Relatives/ Foreign Company)

23.71

Total 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the manufacturing of pharmaceuticals formulations with focus developing value-added (Novel Drug Delivery Systems) single ingredients and novel combination products in the solid oral dosage forms. (Registered Activity)

 

 

Products / Services :

Item Code No.

Products/Services Description

30044020

Pharmaceutical Products and Formulations

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

Banker Name :

HDFC Bank Limited

Branch :

Senapati Bapat Marg, Lower Parel (West), Mumbai-400013, Maharashtra, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Foreign currency term loans from banks

202.120

228.179

Short-term borrowings

 

 

Rupee term loans from banks

5.917

0.000

Foreign currency term loans from banks

240.973

305.147

Total

449.010

533.326

 

Auditors :

 

Name :

SRBC and Company LLP

Chartered Accountants

Address :

14th Floor, The Ruby, 29 Senapati Bapat Marg, Dadar (West), Mumbai – 400028, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

ACHFS9117R

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates/Subsidiaries :

Not Divulged

 

 

CAPITAL STRUCTURE

 

As on 02.06.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

INR 10/- each

INR 100.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

7833000

Equity Shares

INR 10/- each

INR 78.330 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.      EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

78.330

78.330

78.330

(b) Reserves and Surplus

1608.274

1421.745

1306.692

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1686.604

1500.075

1385.022

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

202.120

228.179

247.036

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long-term liabilities

18.965

3.269

9.808

(d) long-term provisions

8.866

15.091

10.039

Total Non-current Liabilities (3)

229.951

246.539

266.883

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

246.890

305.147

122.585

(b) Trade payables

402.152

336.866

240.339

(c) Other current liabilities

149.101

123.141

144.843

(d) Short-term provisions

1.494

65.976

26.064

Total Current Liabilities (4)

799.637

831.130

533.831

 

 

 

 

TOTAL

2716.192

2577.744

2185.736

 

 

 

 

II.    ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

915.660

1088.496

1060.443

(ii) Intangible Assets

82.163

72.163

9.744

(iii) Tangible assets capital work-in-progress

43.659

7.077

7.979

(iv) Intangible assets under development

380.594

327.569

330.791

(b) Non-current Investments

0.025

0.025

0.025

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

63.561

50.807

51.313

(e) Other Non-current assets

107.627

5.041

3.783

Total Non-Current Assets

1593.289

1551.178

1464.078

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

4.414

0.000

0.000

(b) Inventories

488.210

444.873

353.385

(c) Trade receivables

471.896

435.401

251.478

(d) Cash and bank balances

19.099

40.245

36.196

(e) Short-term loans and advances

138.011

104.894

79.232

(f) Other current assets

1.273

1.153

1.367

Total Current Assets

1122.903

1026.566

721.658

 

 

 

 

TOTAL

2716.192

2577.744

2185.736

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Revenue from operations

2660.566

2338.614

1996.524

 

Other Income

30.068

62.830

35.315

 

TOTAL

2690.634

2401.444

2031.839

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

916.392

785.516

646.668

 

Purchases of Stock-in-Trade

364.800

435.822

386.198

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

9.022

(32.429)

(26.048)

 

Employee benefit expense

438.972

411.604

370.847

 

Exceptional items

0.000

0.000

27.766

 

CSR expenditure

1.700

1.010

0.000

 

Other expenses

578.772

440.153

401.752

 

TOTAL

2309.658

2041.676

1807.183

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

380.976

359.768

224.656

 

 

 

 

 

Less

FINANCIAL EXPENSES

33.023

53.991

24.147

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

347.953

305.777

200.509

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

110.816

99.580

98.110

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

237.137

206.197

102.399

 

 

 

 

 

Less

TAX

50.609

44.005

21.272

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

186.528

162.192

81.127

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

23.81

20.71

10.36

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

110.277

108.532

125.774

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

370.867

100.663

90.069

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

64.74

67.96

45.97

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

5.64

5.37

7.94

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

114.57

100.67

84.93

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.78

0.81

0.64

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.27

0.24

0.16

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.41

0.45

0.41

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.33

0.43

0.36

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.47

0.55

0.39

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.84

1.00

1.02

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

11.54

6.66

9.30

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

7.01

6.94

4.06

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

6.87

6.29

3.71

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

11.06

10.81

5.86

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.40

1.24

1.35

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.79

0.70

0.69

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.62

0.58

0.63

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

7.14

8.19

6.32

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.40

1.24

1.35

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

78.330

78.330

78.330

Reserves & Surplus

1306.692

1421.745

1608.274

Net worth

1385.022

1500.075

1686.604

 

 

 

 

long-term borrowings

247.036

228.179

202.120

Short term borrowings

122.585

305.147

246.890

Current maturities of long-term debts

125.774

108.532

110.277

Total borrowings

495.395

641.858

559.287

Debt/Equity ratio

0.358

0.428

0.332

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1996.524

2338.614

2660.566

 

 

17.134

13.767

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1996.524

2338.614

2660.566

Profit

81.127

162.192

186.528

 

4.06%

6.94%

7.01%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of establishment

Yes

2]

Constitution of the entity Incorporation details

Yes

3]

Locality of the entity

Yes

4]

Premises details

No

5]

Buyer visit details

--

6]

Contact numbers

Yes

7]

Name of the person contacted

No

8]

Designation of contact person

No

9]

Promoter’s background

Yes

10]

Date of Birth of Proprietor / Partners / Directors

Yes

11]

Pan Card No. of Proprietor / Partners

Yes

12]

Voter Id Card No. of Proprietor / Partners

No

13]

Type of business

Yes

14]

Line of Business

Yes

15]

Export/import details (if applicable)

No

16]

No. of employees

No

17]

Details of sister concerns

No

18]

Major suppliers

No

19]

Major customers

No

20]

Banking Details

Yes

21]

Banking facility details

Yes

22]

Conduct of the banking account

--

23]

Financials, if provided

Yes

24]

Capital in the business

Yes

25]

Last accounts filed at ROC, if applicable

Yes

26]

Turnover of firm for last three years

Yes

27]

Reasons for variation <> 20%

--

28]

Estimation for coming financial year

No

29]

Profitability for last three years

Yes

30]

Major shareholders, if available

Yes

31]

External Agency Rating, if available

Yes

32]

Litigations that the firm/promoter involved in

--

33]

Market information

--

34]

Payments terms

No

35]

Negative Reporting by Auditors in the Annual Report

No

 

NOTE: Registered office of the company has been shifted from Unit S-4, Khira Industrial Premises Co Opeartive Society Limited, B M Bhargava Road, Santacruz (West), Mumbai-400054, Maharashtra, India  to the present address w.e.f. 01.12.2012

 

CORPORATE INFORMATION

 

The Company, incorporated in 1985 is engaged in the manufacturing of pharmaceuticals formulations with focus developing value-added (Novel Drug Delivery Systems) single ingredients and novel combination products in the solid oral dosage forms.

 

INDEX OF CHARGES

 

S

No

SRN

Charge Id

Charge Holder Name

Date of Creation

Amount

Address

1

G47090378

100105993

HDFC BANK LIMITED

08/06/2017

500000000.0

SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

2

G47011275

100105729

HDFC BANK LIMITED

07/06/2017

500000000.0

SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

3

G07564495

100038740

HDFC BANK LIMITED

04/07/2016

125000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

4

G07508203

100038538

HDFC BANK LIMITED

23/06/2016

125000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

5

C59791806

10581860

HDFC BANK LIMITED

14/07/2015

200000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

6

C57778987

10577619

HDFC BANK LIMITED

16/06/2015

200000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

7

C28817997

10525059

HDFC Bank Limited

13/10/2014

125000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

8

C28300317

10524647

HDFC Bank Limited

25/09/2014

125000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

9

B78544640

10434417

11/06/2013

300000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

10

B74503897

10423953

09/04/2013

300000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (WEST) MUMBAI MAHARASHTRA 400013 INDIA

 

 

CONTINGENT LIABILITIES:

 

PARTICULARS

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Disputed Excise Duty Liability (only penalty)

5.239

5.239

Disputed Service Tax Liability (including penalty)

6.427

6.427

Total

11.666

11.666

 

 

FIXED ASSETS

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.85

UK Pound

1

INR 79.97

Euro

1

INR 90.58

 

 

INFORMATION DETAILS

 

Information Gathered by :

SHA

 

Analysis Done by :

NIS

 

 

Report Prepared by :

JYTK

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.

 
 

·